R egion al M e ta sta sis in H ead an d N eck S q u am ou s C<fll C arcinom a: R ev ised V alue o f US w ith U S-guided FN A B1
PURPOSE: To verify the acclaimed accuracy of ultrasound (US) combined with US-guided fine-needle aspiration biopsy (FNAB) in the detection of lymph node metastasis in the neck and to evaluate the interobserver variability.
MATERIALS AND METHODS:
In a prospective, multicenter study of 185 patients with head and neck squamous cell carcinoma, US (n = 238 neck sides) with US-guided FNAB (n = 178 neck sides) was used for evaluation of the lymph node status of the neck. Findings were correlated with those of histo pathologic examination in 238 neck sides.
RESULTS: US with US-guided FNAB had a sensitivity of 77% and a speci ficity of 100%. Nineteen of 178 aspira tions were nondiagnostic. There were no significant differences between the four participating hospitals or the individual sonologists (P > .05). CONCLUSION: Sensitivity of US with US-guided FNAB was slightly lower compared with previous re ports. Specificity was similar to pre vious reports. Interobserver variabil ity appeared to be low. The validity of US with US-guided FNAB is high and warrants widespread use of the procedure for evaluation of the neck.
T h e status of the lymph nodes in the neck is crucial to the treat ment and prognosis of patients with head and neck squamous cell carci noma (SCC). The prognosis is mainly determined on the basis of nodal dis ease: The presence of a single cervical lymph node metastasis in the ipsilateral side of the neck decreases the ex pected survival by approximately 50%. A contralateral affected node also re duces the expected survival by half (1) .
In general, a patient with head and neck SCC and regional metastasis will be treated with irradiation of the neck, surgery, or both, Even w hen no nodes are detected, most head and neck oncologists will treat the neck electively w hen (clinically undetec ted) regional metastasis is likely. In most hospitals, elective neck treat ment will be performed if the fre quency of occult metastasis is more than 15%, In clinical practice, this means that patients with oral, oro pharyngeal, hypopharyngeal, or su pra-and subglottic laryngeal carcino mas will be treated electively for the lymph nodes of the neck (2) , If the probability of regional metastasis is reduced, the number of elective treat ments will be decreased (2) .
Until recently, accurate assessment of the neck of patients with head and neck SCC was not possible. Palpation and lymphangiography are not reli able (3) (4) (5) . Magnetic resonance (MR) imaging and computed tomography (CT) are useful (6-10); however, these are expensive and not always avail able. In addition, differentiation be tween nodes with and those without métastasés on the basis of radiologic characteristics only has a relatively low specificity (4, 9, (11) (12) (13) (14) (15) (16) (17) . Immuno logic assays may prove to be useful in the future but are still under investi gation (18) , Ultrasound (US) of the neck combined with US-guided fineneedle aspiration biopsy (FNAB) was dem onstrated to be very accurate in the evaluation of regional metastatic disease (13, 19, 20) . This technique combines the high sensitivity of US with the excellent specificity of FNAB (21) (22) (23) (24) . A sensitivity of 98% and a speci ficity of 95% have been reported (20) .
In view of the test characteristics of US with US-guided FNAB, this diag nostic procedure may have a substan tial impact on clinical management of patients with head and neck SCC (2) . O pponents have suggested, however, that the results of both US and USguided FNAB are very much deter mined by the expertise of those who perform the investigation. Therefore, a prospective, multicenter study on the value of US with US-guided FNAB was undertaken.
The object of our study was to verify the acclaimed accuracy of US with US-guided FNAB in the diagno sis of metastatic neck disease in pa tients with head and neck SCC. A second objective was to investigate w hether major differences in the ac curacy of the combined procedure occur w hen the tests are performed by different investigators. Further more, we studied other factors that could possibly influence the results of US with US-guided FNAB (eg, pri mary tumor site and node level).
M ATERIALS A N D M ETHODS
The multicenter study was performed at four hospitals in The Netherlands by 39
Abbreviations: FNAB = fine-needle aspiration biopsy, SCC = squamous cell carcinoma. were recorded on a worksheet. Subse quently, US-guided FNAB of nodes that were depicted with US was performed in 178 cases. In case of multiplicity, USguided FNAB was performed of the larg est node, nodes showing central hypoechogeneity, or the most cranial and caudal nodes in the areas at highest risk for metastasis. The US examinations and the US-guided FNABs were performed with the following scanners: a model 620/ 650CL (Aloka, Tokyo, Japan), with a 7.5-MHz linear-array probe; a model SSA 250A (Toshiba Europe, Zoetermeer, The Netherlands), with a 7.5-MHz mechanical sector type of probe with a built-in water path; and a model 128 XP (Acuson, Moun tain View, Calif), with a 7-MHz linear-ar ray probe. The procedure was performed as described previously (20, 25) (Figure) . Cytologic examination was performed by experienced cytopathologists, Nondiag nostic aspirations had to be repeated. Be cause the trauma associated with rigid en doscopy may cause an increase in the number and size of lymph nodes, both palpation and US were preferably per formed before endoscopy.
Neck dissection had to be performed within 3 weeks. The specimen was labeled by the surgeon as level I-V, according to the Memorial Sloan-Kettering classifica tion (26) . Subsequently, histologic exami nation of the neck dissection specimen was performed according to a standard ized protocol, and the findings of the pa thologist (J.H.J.M.v.K., F.T.B., S.C.H.L., J.M.W.v.T.) were recorded per level. The results of palpation and US with USguided FNAB were compared with the results of the histopathologic examination. We considered the results per neck side since the treatment of metastatic disease is for a neck rather than for a single node: The detection of a single metastasis results in the treatment of the whole neck side. Moreover, it is practically impossible to match an aspirated or palpable node with the same node in the neck dissection specimen.
The test result of US with US-guided FNAB in fact consisted of the combined results of two separate tests: US and USguided FNAB (Table 1) . US may be scored positive (lymph nodes depicted) or nega tive (no lymph nodes visualized), No mor phologic criteria were used. Merely the depiction of lymph nodes, therefore, was used for scoring the result of US. USguided FNAB may be (a) not performed, (fa) negative (reactive), (c) positive (meta static), or (d) nondiagnostic. Therefore, five combinations of test results were dis tinguished. The cases with nondiagnostic aspirates (not repeated or repeatedly non diagnostic) were excluded. Therefore, US with US-guided FNAB was considered negative if (a) no nodes could be visual ized, (b) nodes were too small to aspirate (< 5 mm), or (c) nodes appeared to be re active at cytologic examination. The test was considered positive if the aspirate contained tumor cells.
The reference standard (histopathologic examination) was considered negative when no evidence of metastases was found in neck dissection specimens and positive when one or more metastases were diagnosed.
Since the main objective of this study was to establish the value of US with USguided FNAB in the discrimination be tween neck sides with or without metastatic disease, the result of US-guided FNAB of one or more nodes was considered to be representative for the neck as a whole. In other words, when US-guided FNAB for example showed a reactive node that was confirmed with histopathologic examina tion but a metastasis was found in another lymph node that was not depicted at US, the test result was considered false-nega tive.
Differences in test characteristics such as sensitivity and specificity were evaluated by using the x2 test. Differences were con sidered statistically significant at P < ,05.
RESULTS
A total of 185 patients (133 men, 52 women; age range, 25-85 years; mean age, 59 years) participated in this study, Of these, 132 patients under went unilateral and 53 patients un derwent bilateral neck dissection, re sulting in the inclusion of 238 neck sides. The primary tumor sites and tumor stages are listed in Table 2 .
Palpation and US with US-guided FNAB
The results of US with US-guided FNAB are shown in Table 1 . With pal pation, a sensitivity of 66% and a specificity of 92% were achieved (Table 3 ). For US with US-guided FNAB, a sensitivity of 77% and a specificity of 100% were found (Table  3) . Some nodes detected with palpa tion were not detected by using US with US-guided FNAB. Therefore, the results of palpation and US with USguided FNAB are supplementary. When, as is done in clinical practice, the results of US with US-guided FNAB and palpation were combined, the sensitivity was 80% with a speci ficity of 92%.
Lymph node metastasis. US image obtained during US-guided FNAB. Tip of the needle is depicted as a hyperechoic spot (arrow). For this image, a 10-MHz sector-type probe with a built-in water path was used to obtain an optimal graphical representation.
A considerable proportion of the aspirates (19 of 178 cases) were nondi agnostic, and FNAB was not repeated. In fact, in most cases of initially non diagnostic aspirates, FNAB was not repeated. Histologic examination of the neck dissection specimens re vealed that 12 of these specimens in fact contained metastases and seven had reactive nodes, This might sug gest that a nondiagnostic aspirate is more likely to be from a metastatic node. However, the proportion of metastatic nodes (12 of 19 nodes) re flects the prevalence of lymph node metastases in the entire population (155 of 238 cases). For the present study, the nondiagnostic aspirates were excluded.
Sonologists and Hospitals
To evaluate the interobserver variabil ity, we compared the results of six son ologists who examined at least 13 neck sides (varying from 13 to 53 neck sides) and the combined results of a group of 33 sonologists (78 neck sides) who per formed the examination less frequently. No statistically significant differences were found between the characteristics of these (groups of) sonologists (Table 3) or between the participating hospitals (data not shown, P = .14).
Primary Tumor Sites and N eck Levels
The results of US with US-guided FNAB for different primary tumor sites are summarized in Table 3 , Al though there seem to be marked dif ferences, note that the number of cases in some of the groups is fairly small. There were no statistically sig nificant differences in sensitivity for the different primary sites (P = .51), To evaluate differences in detecting métastasés in lymph nodes of the dif ferent neck levels (I-V), we investi gated whether métastasés were missed more often in particular regions. The number of lymph node métastasés per level was listed, and the fraction of mé tastasés not detected by using US with US-guided FNAB was calculated. No statistically significant differences were found between the various levels (P = .52) ( Table 4) .
DISCUSSIO N
To assess the status of lymph nodes in the neck in patients with head and neck SCC, various (imaging) tech niques have been explored. CT and MR imaging allow detection of small structures, such as lymph nodes, with high sensitivity. Although several ra diologic characteristics of metastatic nodes have been defined (size, shape, central necrosis, obliteration of fascial planes, contiguous nodes), several authors have criticized these criteria (4, 12, (15) (16) (17) (27) (28) (29) . In our opinion, differentiation between benign and metastatic nodes only on the basis of radiologic characteristics remains dif ficult and unreliable.
US is characterized by a superior sensitivity rate for detection of lymph nodes (3, 30) . The detection of more lymph nodes, however, inevitably leads to a lower specificity; A consid erable proportion of the lymph nodes detected with US will be benign. As with CT and MR imaging, differentia tion between reactive and metastatic nodes is based on morphologic crite ria (13, 28, 31) . This leads to a relatively low specificity, although some au thors reported high specificity rates up to 91% with US alone (30).
With the introduction of the con cept of US-guided FNAB (19, 20) , the high sensitivity of US is combined with the high specificity of cytologic examination (20) . Sensitivity and specificity have been reported as high as 98% and 95%, respectively. In a subsequent similar study, other au thors reported an even higher speci ficity of 100% but at the expense of a lower sensitivity of 90% (13). Critics, however, doubted that these rates could be reproduced if the technique was performed by different sonolo gists in "daily practice/ 7
In our study, only patients under going neck dissection as part of their treatment were included because his tologic examination was used as the standard of reference. Although this introduces an inevitable bias by in creasing the number of cases with metastatic disease, all reports of stud ies of US with US-guided FNAB, CT, or MR imaging are subject to this limi tation.
The accuracy and sensitivity of US with US-guided FNAB in our study were not as high as found in previous studies. The specificity, however, was comparable. Compared with other diag nostic imaging techniques, the sensitiv ity of US with US-guided FNAB found in our study is in the range of that re ported for CT (4, 6, 9, 12, 13, 15, 16) and MR imaging (5, 9) . The high specificity of up to 100% found in the present and previ ous studies (13,20) compares favorably with that of CT and MR imaging. Most studies concerning CT found a specificity of no more than 70%-85% (4, 9, 12, 13, 15, 16) . A few studies found higher specificity rates (up to 94%) by using morphologic criteria (28) .
In most studies concerning the value of CT and MR imaging for assessment of the neck, morphologic and/or size crite ria are used. By choosing an optimal cutoff point, false-positive and falsenegative results will be introduced. As a consequence, in these studies, a higher sensitivity results in a lower specificity and vice versa. For example, Stevens et al (12), Close et al (15), Hillsamer et al (9) , and Friedman et al (11) found sensitivity rates of 97%, 86.5%, 84%, and 95% paired to a much lower specificity of 82%, 71%, 71%, and 77%, respectively. In contrast, Feinmesser et al (4) found a relatively low sensitivity of 60% with a higher specificity of 85%. Although US alone suffers from the same phenom enon, US with US-guided FNAB does not because US determines the sensitiv ity and US-guided FNAB the specificity.
Another factor influencing the re sults of these studies is the frequency of metastasis. Studies with a high number of patients having metastasis or advanced-stage disease will show higher sensitivity rates for the studied diagnostic techniques. For example, in studies with a relatively high number of cases with clinically or histologi cally positive nodes, higher sensitivity rates for CT were obtained, up to 91 % (6, 12, 15) , whereas in studies with more cases with negative nodes, sensitivity rates for CT were lower (eg, 60%) (4). The only study, to our knowledge, in which the results of US with US-guided FNAB, CT, and MR imaging were com pared in the same study population showed superior results of US wi th USguided FNAB (13). Another advantage of US with USguided FNAB over CT and MR imag ing is the lower cost (in the Nether lands, the costs of CT are about four times as high as those of US with USguided FNAB). Moreover, for US with US-guided FNAB, patients do not have to lie dow n (for a prolonged pe riod of time), which is more conve nient in these predominantly elderly and/or dyspneic patients. Contrary to CT and especially MR imaging, US will not be problematic in patients inclined to be claustrophobic. Finally, in our opinion, FNAB is hardly a more invasive or risky procedure than the administration of intravenous contrast material in CT or MR imaging.
Unfortunately, in 19 cases of nondi agnostic aspirates, FNAB was not re peated. Repeating these aspirations, as was requested according to the protocol, would definitely have im proved the test results. We cannot, Ziowever, prove this with our material because for most cases of nondiagnos tic aspirates, FNAB was not repeated. The rate of nondiagnostic US-guided FNABs (19 [11%] of 178 aspirates) is in the range found in previous studies (1%-15%) (20, 32, 33) .
Our data show that the results of US with US-guided FNAB are not as investigator dependent as often sug gested. No major differences were found between experienced and less experienced sonologists.
Although the differences were not statistically significant, it appeared that the accuracy of US with USguided FNAB was determined by the site of the primary tumor. There are two explanations for this finding. First, this may be due to a difference in frequency (Table 3) . This influ ences, in particular, the negative and positive predictive values. Second, different primary tumors metastasize to different neck levels, and lymph node metastases in some levels are more difficult to detect by using US with US-guided FNAB than others. This phenomenon has been described in earlier studies (34, 35) , In our study, it seemed more difficult to detect lymph node metastases in levels I and V than in levels II, III and IV, although the differences were not statistically sig nificant. Therefore, the favorable sensi tivity rates for laryngeal and pharyngeal carcinoma when compared with floor of mouth or oropharyngeal carcinoma may be because the former metastasize less frequently to level I.
The difficulty in the detection of nodes in level I by using US with USguided FNAB may be caused by the mandible. However, nodes missed with US at this level may be detected with palpation: With bimanual pal pation, examination of level I is rela tively easy to perform. If the results of palpation are added to the results of US with US-guided FNAB in cancer of the floor of mouth, a primary tumor predominantly metastasizing to level I, sensitivity improves from 57% to 79% at the expense of a specificity declining from 100% to 83%. It seems justified, therefore, to use the combi nation of the results of both methods of examination in clinical practice (Table 3) .
In this prospective, multicenter study, the sensitivity ofU Sw ith USguided FNAB appeared to be slightly lower compared with that of previous studies but comparable with the sen sitivity of CT and MR imaging. The specificity of US with US-guided FNAB found in our study is similar to that of previous studies and superior to the specificity of CT and MR imag ing. Repeating FNAB for nondiagnos tic aspirates may further improve the test characteristics of US with USguided FNAB.
Palpation remains an important tool for assessment of the lymph nodes of the neck, A combination of palpation and US with US-guided FNAB improves the sensitivity of the diagnostic procedure. In addition, in this study, the often suggested in terobserver variability of US and USguided FNAB could not be confirmed. The results of this study can be con sidered as a validation of and recom mendation for the use of US with USguided FNAB for evaluation of the neck in patients with head and neck SCC. ■
